GLP-1 agonists in Parkinson’s disease: New evidence, new questions?
MDS Podcast features Dr. Michele Matarazzo interviewing Prof. Tom Foltynie about the phase 3 clinical trial of exenatide for Parkinson's disease, published in The Lancet. They discuss the disappointing findings and ongoing analyses to understand the results and future…